July 18th 2016EP. 1: Value of Early Diagnosis of PAH in Managed Care
July 18th 2016EP. 2: Proxy Endpoints to Understand Outcomes and Guide Treatment in PAH
July 18th 2016EP. 3: The Underlying Pathophysiology of Pulmonary Arterial Hypertension
July 18th 2016EP. 4: The Effect of Delayed Diagnosis of PAH and Identifying Patients Earlier
July 18th 2016EP. 5: Evolution in Clinical Trial Design: Measuring PAH Treatment Efficacy
July 18th 2016EP. 6: Incorporating Newer Oral PAH Medications
July 18th 2016EP. 7: Factors Impacting Formulary Decision-Making in PAH
July 18th 2016EP. 8: Outcomes Assessment and Combination Therapy in PAH
July 18th 2016EP. 9: Prostacyclins in PAH: Selecting Among the Agents
July 18th 2016EP. 10: Understanding the Newer Options in PAH
July 18th 2016EP. 11: The Importance of a Patient-Centered Approach in PAH
July 18th 2016EP. 12: Long-Term Outcomes and Managing PAH Costs
July 18th 2016EP. 13: PAH: Multidisciplinary Care and Medication Benefits
July 18th 2016EP. 14: Optimizing PAH Treatment in Managed Care
July 18th 2016EP. 15: Hospitalization in PAH
July 18th 2016EP. 16: PAH Treatment Driven by Data From Peer-Reviewed Literature
July 18th 2016EP. 17: Managed Care's Role in Future Treatment of PAH
July 18th 2016EP. 18: The Future of PAH
